Business Context and Reporting Period
This Form 8-K filing by Global Medical REIT Inc. (not Chiron Real Estate Inc.) reports events occurring on September 25, 2015, with the report filed on October 1, 2015. The filing details the completion of an asset acquisition and the associated financing arrangements.
Key Financial Metrics and Transaction Details
- Acquisition: Purchased a 27,193 square foot surgery center and medical office building in West Mifflin, Pennsylvania, for a total purchase price of $11.35 million.
- Financing (Debt): Secured a term loan of $7,377,500 from Capital One, National Association, maturing on September 25, 2020.
- Loan Terms: Interest rate of 3.72% per annum; interest-only payments begin November 1, 2015, with amortization starting November 1, 2018. A 2% early termination fee applies if prepaid before September 25, 2018.
- Equity/Debt Contribution: Received $4,545,838 from its majority shareholder to partially fund the transaction. This amount is recorded as an unsecured Convertible Debenture bearing 8% annual interest, convertible into common stock at a price of $12.748 per share.
- Transaction Costs: Paid a non-refundable commitment fee of $73,775 to the lender.
- Lease Terms: The facility is leased back to the tenants for 15 years with two 5-year renewal options.
Material Changes
The filing represents a material change in the Company's asset base and capital structure. The Company has added a new income-producing property to its portfolio and increased its debt obligations by $7.38 million in bank debt and $4.55 million in shareholder debt. No prior comparable period financial metrics (revenue, profit, cash flow) are provided in this specific filing as it focuses on a discrete transaction event.
Outlook, Risks, and Contingencies
- Future Filings: Required financial statements of the acquired business and pro forma financial information are not included in this report and will be filed by amendment within 71 calendar days.
- Prepayment Restrictions: The Company cannot prepay the Capital One loan in whole or in part prior to September 25, 2017.
- Shareholder Conversion: The majority shareholder holds the right to convert the $4.55 million debenture into common stock, which could result in dilution of existing shareholders.
Investor Verification Checklist
- Verify the upcoming filing of pro forma financial information to assess the impact of the acquisition on the Company's overall financial health.
- Confirm the creditworthiness and lease stability of the tenants (Associates in Ophthalmology, LTD and Associates Surgery Centers, LLC).
- Monitor the Company's liquidity to ensure it can meet the interest-only payments starting November 1, 2015, and the eventual amortization payments starting in 2018.
- Review the terms of the Convertible Debenture to understand potential dilution scenarios if the majority shareholder exercises conversion rights.